![Low-dose Methotrexate patient's action plan | Rheumatoid Arthritis (RA) support program - homepage | Arthritis Australia Low-dose Methotrexate patient's action plan | Rheumatoid Arthritis (RA) support program - homepage | Arthritis Australia](https://myra.org.au/sites/default/files/inline-images/Road%20Map%202%20Large.jpeg)
Low-dose Methotrexate patient's action plan | Rheumatoid Arthritis (RA) support program - homepage | Arthritis Australia
![Supporting safe practices for low-dose methotrexate - Council of Australian Therapeutic Advisory Groups (CATAG) Supporting safe practices for low-dose methotrexate - Council of Australian Therapeutic Advisory Groups (CATAG)](https://catag.org.au/wp-content/uploads/CATAG-Position-Statement-on-the-use-of-low-dose-methotrexate-1-1-pdf-1.jpg)
Supporting safe practices for low-dose methotrexate - Council of Australian Therapeutic Advisory Groups (CATAG)
![High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma - ScienceDirect High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419478630-gr1.jpg)
High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma - ScienceDirect
![Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis | Scientific Reports Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-75655-9/MediaObjects/41598_2020_75655_Fig1_HTML.png)
Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis | Scientific Reports
![High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet](https://www.thelancet.com/cms/attachment/2001002082/2003731510/gr1.gif)
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet
![A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities | SpringerLink A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00280-018-3733-2/MediaObjects/280_2018_3733_Fig1_HTML.png)
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities | SpringerLink
![Assessment of High-Dose Methotrexate Management Guideline in Adults with Cancer at an Academic Medical Center Assessment of High-Dose Methotrexate Management Guideline in Adults with Cancer at an Academic Medical Center](https://jhoponline.com/images/jhop/2021/April/AssessHigh-Dose_table1.jpg)
Assessment of High-Dose Methotrexate Management Guideline in Adults with Cancer at an Academic Medical Center
![Comparison of Intermediate-Dose Methotrexate with Cranial Irradiation for the Post-Induction Treatment of Acute Lymphocytic Leukemia in Children | NEJM Comparison of Intermediate-Dose Methotrexate with Cranial Irradiation for the Post-Induction Treatment of Acute Lymphocytic Leukemia in Children | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1983/nejm_1983.308.issue-9/nejm198303033080902/20130822/images/img_medium/nejm198303033080902_t12.jpeg)
Comparison of Intermediate-Dose Methotrexate with Cranial Irradiation for the Post-Induction Treatment of Acute Lymphocytic Leukemia in Children | NEJM
![Oral to Subcutaneous Methotrexate Dose-Conversion Strategies in the Treatment of Rheumatoid Arthritis - ACR Meeting Abstracts Oral to Subcutaneous Methotrexate Dose-Conversion Strategies in the Treatment of Rheumatoid Arthritis - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2015/09/Paper_48361_abstract_59045_0.png)
Oral to Subcutaneous Methotrexate Dose-Conversion Strategies in the Treatment of Rheumatoid Arthritis - ACR Meeting Abstracts
![High‐dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15‐year multicenter experience - Yoon - 2021 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library High‐dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15‐year multicenter experience - Yoon - 2021 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/132c0e16-fddd-462e-abc1-eadcdcfd7189/ajco13427-gra-0001-m.jpg?trick=1672059102090)
High‐dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15‐year multicenter experience - Yoon - 2021 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
![High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma | Blood Cancer Journal High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-021-00535-y/MediaObjects/41408_2021_535_Fig1_HTML.png)
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma | Blood Cancer Journal
![Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack - ScienceDirect Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022510X20302720-t1.jpg)
Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack - ScienceDirect
Methotrexate-associated toxicity in children with Down syndrome and acute lymphoblastic leukemia during consolidation therapy with high dose methotrexate according to ALL-BFM treatment regimen | Haematologica
![High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial - The Lancet Oncology High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2001026129/2003901555/gr1.gif)
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial - The Lancet Oncology
![A single-center qualitative study evaluating the safety and efficacy of a pharmacist-driven protocol for high-dose methotrexate management - Stephanie F Matta, Leslie A Gieselman, Robert S Mancini, 2021 A single-center qualitative study evaluating the safety and efficacy of a pharmacist-driven protocol for high-dose methotrexate management - Stephanie F Matta, Leslie A Gieselman, Robert S Mancini, 2021](https://journals.sagepub.com/cms/10.1177/1078155220927455/asset/images/large/10.1177_1078155220927455-fig1.jpeg)